Izomeraza fosfoglukozowa – „portret białka o wielu twarzach”
Słowa kluczowe:
isomerase, biological function, clasiffication structures, mechanizm of reactionAbstrakt
W artykule przeglądowym przedstawiono biologiczne funkcje, klasyfikację, struktury, mechanizmy reakcji i potencjalne zastosowanie izomerazy fosfoglukozowej
i inhibitorów tego enzymu.
Wiedza o różnych biologicznych procesach, w których zaangażowana jest PGI może być bardzo pomocna w leczeniu nowotworów, bakterioz, grzybic i parazytoz.
Bibliografia
1. Anand K. et al.: Structural studies of phosphoglucose isomerase from Mycobacterium tuberculosis H37Rv. Acta Cryst. Section F, F66, 490-497, 2010.
2. Arsenieva D. et al.: The crystal structure of rabbit phosphoglucose isomerase complexed with 5-phospho-D-arabinohydroxyamic acid. Proc. Natl. Acad. Sci. USA, 99, 5872-5877, 2002.
3. Bateman A.: The SIS domain: a phosphosugar-biding domain. Trends Biochem. Sci., 24, 94-95, 1999.
4. Bateman A. et al.: The Pfam protein families database. Nucleic Acids Res., 28, 263-266, 2000.
5. Baumann M. and Brand K.: Purification and characterization of phospohexose isomerase from human gastrointestinal carcinoma and its potential relationship to neuroleukin. Cancer Res., 48, 7018-7021, 1988.
6. Baumann M. et al.: The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney and breast cancer. Cancer Invest., 8, 351-356.
7. Berrisfold J.M. et al.: The structures of inhibitor complexes of Pyrococcus furiosus phosphoglucose isomerase provide insights into substrate binding and catalysis. J. Mol. Biol., 343, 649-657, 2004.
8. Cao M.J. et al.: Purification of a novel serine proteinase inhibitor from the skeletal muscle of white croacker (Argyrosomus argentatus). Biochem. Biophys. Res. Commun., 272, 485-489, 2000.
9. Chaput M. et al.: The neutrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature, 332, 454-455, 1988.
10. Davies C. et al.: The structure of human phosphoglucose isomerase complexed with
a transition-state analoque. Acta Crystallogr. Sect. D Biol. Crystallogr., 59, 1111-1113, 2003.
11. Filella X. et al.: Serum phosphohexose isomerase activities in patients with colorectal cancer. Tumour Biol., 12, 360-367, 1991.
12. Gurney M.E. et al.: Molecular cloning and expression of neuroleukin a neutrophic factor for spinal and sensory neurons. Science, 234, 566-574, 1986.
13. Gurney M.E. Neuroleukin: basic biology and functional interaction with human immunodeficiency virus. Immunol. Rev., 100, 203-223, 1987.
14. Hansen T. et al.: Novel type of glucose-6-phosphate isomerase in the hyperthermophilic Archaeon Pyrococcus furiosus. J. Bacteriol., 183, 3428-3435, 2001.
15. Hansen T. et al.: Cupin-type phosphoglucose isomerases (Cupin-PGIs) constitute a novel metal-dependent PGI family representing a convergent line of PGI evolution. J. Bacteriol., 187, 1621-1631, 2005.
16. Hansen T. et al.: Bifunctional phosphoglucose/phosphomannose isomerase from the Archaea Aeropyrum pernix and Thermoplasma acidophilum constitute a novel enzyme family within the phosphoglucose isomerase superfamily. J. Biol. Chem., 279, 2262-2272, 2004.
17. Hardre R. et al.: Synthesis and evaluation of a new inhibitor of phosphoglucose isomerase: the enediolate analogue 5-phospho-D-arabinohydroxymate. Bioorg. Med. Chem. Lett., 8, 3435-3438, 1998.
18. Hirono Y. et al.: Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer. Br. J. Cancer, 74, 2003-2007, 1996.
19. Jeffery C.J.: Moonlighting proteins. Trends Biochem. Sci., 24, 8-11, 1999.
20. Jeffery C.J.: Moonlighting proteins: old proteins learning new tricks. Trends Genet. Sci., 19, 415-417, 2003.
21. Jeong J.-J. et al.: Characterization of the cupin phosphoglucose isomerase from the hyperthermophilic archaeon Thermococcus litoralis. FEBS Lett., 535, 200-204, 2003.
22. Kugler W., et al.: Glucose-6-phosphate isomerase deficiency. Baillieres’s Best Pract. Res. Clin. Haematol. 13, 89-101, 2000.
23. Lee J.H. et al.: Crystal structure of rabbit phosphoglucose isomerase complexed with its substrate D-fructose 6-phosphate. Biochemistry, 40, 7799-7805, 2001.
24. Lin H.-Y. et al.: Effects of inherited mutations on catalytic activity and structural stability of human glucose-6-phosphate isomerase expressed in Escherichia coli. Biochim. Biophys. Acta, 1794, 315-323, 2009.
25. Mathur D. and Garg L.: Functional phosphoglucose isomerase from Mycobacterium tuberculosis H37Rv: rapid purification with high yield and purity. Protein Expr. Purif., 52, 373-378, 2007.
26. Milewski S. et al.: Structural analogues of reactive intermediates as inhibitors of glucosamine-6-phosphate synthase and phosphoglucose isomerase. Arch. Biochem. Biophys., 450, 39-49, 2006.
27. Pelicano H. et al.: Glycolysis inhibition for anticancer treatment. Review. Oncogene, 25, 4633-4646, 2006.
28. Richards G. et al.: Characterization of a lysyl aminopeptidase activity associated with phosphoglucose isomerase of Vibrio vulnificus. Biochem. Biophys. Acta, 1700, 219-229, 2004.
29. Richards G.: Structural and functional analyses of phosphoglucose isomerase from Vibrio vulnificus and its lysyl aminopeptidase activity. Biochem. Biophys. Acta, 1702, 89-102, 2004.
30. Rose I.A.: Mechanism of the aldose-ketose isomerase reactions. Adv. Enzymol. Relat. Areas. Mol. Biol, 43, 491-517, 1975.
31. Schaller M. et al.: Raised levels of anti-glucose-6-phophate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis. Ann. Rheum. Dis., 64, 743-749, 2005.
32. Schreyer R. and Böck A.: Phosphoglucose isomerase from Escherichia coli K10: purification, properties and formation under aerobic and anaerobic condition. Arch. Microbiol., 127, 289-298, 1980.
33. Sun L.C. et al.: Glucose-6-phosphate isomerase is endogenous inhibitor to myofibryl-bound serine proteinase of crucian carp (Carassius auratus). J. Agric. Food Chem., 57, 55-49-5555, 2009.
34. Sun Y.-J. et al.: The crystal structure of a multifunctional protein: Phosphoglucose isomerase/autocrine motility factor/neuroleukin. Proc. Natl. Acad. Sci. USA, 96, 5412-5417, 1999.
35. Swan M.K. et al.: Structural evidence for a hydride transfer mechanism of catalysis in phosphoglucose isomerase from Pyrococcus furiosus. J. Biol. Chem., 278, 47261-47268, 2003.
36. Tran S.T. et al.: Cloning and characterization of phosphoglucose isomerase from Sphingomonas chungbukensis DJ77. BMB reports, 42, 172-177, 2009.
37. Tran S.T. et al.: Cloning and characterization of phosphomannose isomerase from Sphingomonas chungbukensis DJ77. BMB reports, 42, 523-528, 2009.
38. Xu W. et al.: The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood, 87, 4502-4506, 1996.
39. Yakirevich E. and Naot Y.: Cloning of a glucose phosphate isomerase/neuroleukin- like sperm antigen involved in sperm agglutination. Biol. Reprod., 62, 1016-1023, 2000.
40. Yoon R.Y. et al.: Substrate specificity of a glucose-6-phosphate isomerase from Pyrococcus furiosus for monosaccharides. Appl. Microbiol. Biotechnol., 83, 295-303, 2009.
41. Verhees C.H. et al.: The phosphoglucose isomerase from the hyperthermophilic Archaeon Pyrococcus furiosus is a unique glycolytic enzyme that belongs to the cupin superfamily. J. Biol. Chem., 276, 40-926-40932, 2001.
42. Watanabe H. et al.: Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res., 56, 2960-2963, 1996.
43. Wojciechowski M. et al.: Glucosamine-6-phosphate synthase, a novel target for antifungal agents. Molecular modeling studies in drug design. Acta Biochem. Polon., 52, 647-653, 2005.
Pobrania
Opublikowane
Numer
Dział
Licencja
Prawa autorskie (c) 2010 Autorzy
Praca jest udostępniana na licencji Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
